12:00 AM
 | 
Dec 24, 2012
 |  BC Week In Review  |  Company News  |  Other News

Bristol-Myers, Multiple Myeloma Research Foundation (MMRF) cancer news

Bristol-Myers joined the MMRF's Personalized Medicine Initiative (PMI), which includes the foundation's CoMMpass study to advance the development of personalized medicine for multiple myeloma (MM). MMRF launched the study last year to follow 1,000 newly diagnosed...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >